Wolverine Trading’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-51,000
| Closed | -$218K | – | 5253 |
|
|
2023
Q1 | $218K | Buy |
+51,000
| New | +$265K | ﹤0.01% | 3334 |
|
|
2022
Q4 | – | Sell |
-57,200
| Closed | -$322K | – | 5482 |
|
|
2022
Q3 | $322K | Buy |
+57,200
| New | +$356K | ﹤0.01% | 3085 |
|
|
2022
Q2 | – | Sell |
-24,000
| Closed | -$120K | – | 6260 |
|
|
2022
Q1 | $120K | Buy |
24,000
+1,100
| +5% | +$3.28K | ﹤0.01% | 4734 |
|
|
2021
Q4 | $57K | Buy |
+22,900
| New | +$56K | ﹤0.01% | 5290 |
|
|
2021
Q3 | – | Sell |
-20,800
| Closed | -$52K | – | 7426 |
|
|
2021
Q2 | $52K | Buy |
20,800
+5,100
| +32% | +$12.2K | ﹤0.01% | 5600 |
|
|
2021
Q1 | $42K | Buy |
+15,700
| New | +$51.3K | ﹤0.01% | 5686 |
|
|
2019
Q3 | – | Sell |
-21,500
| Closed | -$18K | – | 5405 |
|
|
2019
Q2 | $18K | Buy |
21,500
+1,900
| +10% | +$1.75K | ﹤0.01% | 4291 |
|
|
2019
Q1 | $19K | Buy |
19,600
+3,300
| +20% | +$3.48K | ﹤0.01% | 4408 |
|
|
2018
Q4 | $13K | Buy |
16,300
+3,600
| +28% | +$5.92K | ﹤0.01% | 4304 |
|
|
2018
Q3 | $27K | Buy |
12,700
+1,700
| +15% | +$4.21K | ﹤0.01% | 4784 |
|
|
2018
Q2 | $43K | Hold |
11,000
| – | – | ﹤0.01% | 4932 |
|
|
2018
Q1 | $43K | Buy |
+11,000
| New | +$38.7K | ﹤0.01% | 4932 |
|
|
2017
Q4 | – | Sell |
-11,500
| Closed | -$37K | – | 5977 |
|
|
2017
Q3 | $37K | Buy |
+11,500
| New | +$38.4K | ﹤0.01% | 4273 |
|
Other funds holding CTIC
Wolverine Trading's CTIC Position: Q2 2023 in Review
Wolverine Trading sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 15,764 shares — an estimated $67K sold.
Wolverine Trading first reported a position in CTIC in Q1 2018 and held it in 8 quarters. The position peaked at $236K in Q1 2022. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.
- Wolverine Trading reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
- Wolverine Trading sold 15,764 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $67K.
- Wolverine Trading first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q1 2018 and held it in 8 quarters.
- Wolverine Trading's CTI BioPharma Corp. (DE) Common Stock position peaked at $236K in Q1 2022.
- 2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.
Based on Wolverine Trading's 13F filing for Q2 2023, filed 23 Aug 2023.